![Isabelle Riviere](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Isabelle Riviere
Director/Board Member at Centre For Commercialization of Cancer Immunotherapy
Isabelle Riviere active positions
Companies | Position | Start | End |
---|---|---|---|
Centre For Commercialization of Cancer Immunotherapy
![]() Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Director/Board Member | - | - |
Career history of Isabelle Riviere
Former positions of Isabelle Riviere
Companies | Position | Start | End |
---|---|---|---|
JUNO THERAPEUTICS INC | Founder | 05/08/2013 | - |
Statistics
International
United States | 2 |
Canada | 2 |
Operational
Founder | 1 |
Director/Board Member | 1 |
Sectoral
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Juno Therapeutics, Inc.
![]() Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Centre For Commercialization of Cancer Immunotherapy
![]() Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. |
- Stock Market
- Insiders
- Isabelle Riviere
- Experience